{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:30:40Z","timestamp":1783402240231,"version":"3.54.6"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:00:00Z","timestamp":1507161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:00:00Z","timestamp":1507161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s11882-017-0749-3","type":"journal-article","created":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T07:57:51Z","timestamp":1507190271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID)"],"prefix":"10.1007","volume":"17","author":[{"given":"Jan F.","family":"Mieves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Wittke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helma","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Dieter","family":"Volk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Scheibenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif G.","family":"Hanitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,5]]},"reference":[{"key":"749_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1182\/asheducation-2012.1.301","volume":"2012","author":"C Cunningham-Rundles","year":"2012","unstructured":"Cunningham-Rundles C. The many faces of common variable immunodeficiency. Hematology Am Soc Hematol Educ Program. 2012;2012:301\u20135. https:\/\/doi.org\/10.1182\/asheducation-2012.1.301.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"749_CR2","unstructured":"ESID Registry \u2013 Working Definitions for Clinical Diagnosis of PID. 2016. http:\/\/esid.org\/Working-Parties\/Registry\/Diagnosis-criteria. Accessed 4 Feb 2017."},{"issue":"1","key":"749_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","volume":"4","author":"FA Bonilla","year":"2016","unstructured":"\u2022\u2022 Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. International Consensus Document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(1):38\u201359. https:\/\/doi.org\/10.1016\/j.jaip.2015.07.025. Updated international consensus statement on common variable immunodeficiency including diagnostics and clinical symptoms.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"749_CR4","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1378\/chest.14-1961","volume":"147","author":"YH Gao","year":"2015","unstructured":"Gao YH, Guan WJ, Xu G, Lin ZY, Tang Y, Lin ZM, et al. The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: a prospective study. Chest. 2015;147(6):1635\u201343. https:\/\/doi.org\/10.1378\/chest.14-1961.","journal-title":"Chest"},{"issue":"1","key":"749_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","volume":"134","author":"B Gathmann","year":"2014","unstructured":"Gathmann B, Mahlaoui N, Gerard L, Oksenhendler E, Warnatz K, Schulze I, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(1):116\u201326. https:\/\/doi.org\/10.1016\/j.jaci.2013.12.1077.","journal-title":"J Allergy Clin Immunol"},{"key":"749_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","volume":"7","author":"P Maffucci","year":"2016","unstructured":"Maffucci P, Filion CA, Boisson B, Itan Y, Shang L, Casanova JL, et al. Genetic diagnosis using whole exome sequencing in common variable immunodeficiency. Front Immunol. 2016;7:220. https:\/\/doi.org\/10.3389\/fimmu.2016.00220.","journal-title":"Front Immunol"},{"issue":"9","key":"749_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/jmedgenet-2015-103690","volume":"53","author":"DJ Bogaert","year":"2016","unstructured":"Bogaert DJ, Dullaers M, Lambrecht BN, Vermaelen KY, De Baere E, Haerynck F. Genes associated with common variable immunodeficiency: one diagnosis to rule them all? J Med Genet. 2016;53(9):575\u201390. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103690.","journal-title":"J Med Genet"},{"key":"749_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3389\/fimmu.2014.00675","volume":"5","author":"S Goldacker","year":"2014","unstructured":"Goldacker S, Witte T, Huzly D, Schlesier M, Peter HH, Warnatz K. Analysis of specific IgG titers against tick-borne encephalitis in patients with primary antibody deficiency under immunoglobulin substitution therapy: impact of plasma donor origin. Front Immunol. 2014;5:675. https:\/\/doi.org\/10.3389\/fimmu.2014.00675.","journal-title":"Front Immunol"},{"issue":"2","key":"749_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10875-015-0131-y","volume":"35","author":"E Adam","year":"2015","unstructured":"Adam E, Church JA. Antibody levels to Bordetella pertussis and Neisseria meningitidis in immunodeficient patients receiving immunoglobulin replacement therapy. J Clin Immunol. 2015;35(2):213\u20137. https:\/\/doi.org\/10.1007\/s10875-015-0131-y.","journal-title":"J Clin Immunol"},{"issue":"11","key":"749_CR10","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1136\/jcp.2005.031054","volume":"59","author":"S Lear","year":"2006","unstructured":"Lear S, Eren E, Findlow J, Borrow R, Webster D, Jolles S. Meningococcal meningitis in two patients with primary antibody deficiency treated with replacement intravenous immunoglobulin. J Clin Pathol. 2006;59(11):1191\u20133. https:\/\/doi.org\/10.1136\/jcp.2005.031054.","journal-title":"J Clin Pathol"},{"issue":"6","key":"749_CR11","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.jaci.2011.01.035","volume":"127","author":"I Chua","year":"2011","unstructured":"Chua I, Lagos M, Charalambous BM, Workman S, Chee R, Grimbacher B. Pathogen-specific IgG antibody levels in immunodeficient patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG. J Allergy Clin Immunol. 2011;127(6):1410\u20131. https:\/\/doi.org\/10.1016\/j.jaci.2011.01.035.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"749_CR12","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.jaip.2016.09.012","volume":"4","author":"A Sobh","year":"2016","unstructured":"\u2022 Sobh A, Bonilla FA. Vaccination in primary immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(6):1066\u201375. https:\/\/doi.org\/10.1016\/j.jaip.2016.09.012. Current recommendations for vaccination in patients with primary immunodeficiency.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"749_CR13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.clim.2007.04.011","volume":"124","author":"S Goldacker","year":"2007","unstructured":"Goldacker S, Draeger R, Warnatz K, Huzly D, Salzer U, Thiel J, et al. Active vaccination in patients with common variable immunodeficiency (CVID). Clin Immunol (Orlando, Fla). 2007;124(3):294\u2013303. https:\/\/doi.org\/10.1016\/j.clim.2007.04.011.","journal-title":"Clin Immunol (Orlando, Fla)"},{"issue":"2","key":"749_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.clim.2011.07.006","volume":"141","author":"M Kuntz","year":"2011","unstructured":"Kuntz M, Goldacker S, Blum HE, Pircher H, Stampf S, Peter HH, et al. Analysis of bulk and virus-specific CD8+ T cells reveals advanced differentiation of CD8+ T cells in patients with common variable immunodeficiency. Clin Immunol (Orlando, Fla). 2011;141(2):177\u201386. https:\/\/doi.org\/10.1016\/j.clim.2011.07.006.","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"749_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2015.01.002","volume":"178","author":"M Ramesh","year":"2017","unstructured":"Ramesh M, Hamm D, Simchoni N, Cunningham-Rundles C. Clonal and constricted T cell repertoire in common variable immune deficiency. Clin Immunol (Orlando, Fla). 2017;178:1\u20139. https:\/\/doi.org\/10.1016\/j.clim.2015.01.002.","journal-title":"Clin Immunol (Orlando, Fla)"},{"issue":"4","key":"749_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","volume":"8","author":"RA Seder","year":"2008","unstructured":"Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol. 2008;8(4):247\u201358. https:\/\/doi.org\/10.1038\/nri2274.","journal-title":"Nat Rev Immunol"},{"key":"749_CR17","doi-asserted-by":"crossref","unstructured":"Kimberlin DW, Brady MT, Jackson MA, Long SS. Red Book\u00ae: 2015 Report of the Committee on Infectious Diseases, 30th Edition. American Academy of Pediatrics, IL, USA; 2015.","DOI":"10.1542\/9781581109276"},{"issue":"4","key":"749_CR18","first-page":"585","volume":"62","author":"JE Kaplan","year":"1984","unstructured":"Kaplan JE, Nelson DB, Schonberger LB, Hatch MH, Monath TP, Lazuick JS, et al. The effect of immune globulin on the response to trivalent oral poliovirus and yellow fever vaccinations. Bull World Health Organ. 1984;62(4):585\u201390.","journal-title":"Bull World Health Organ"},{"issue":"30","key":"749_CR19","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1016\/j.vaccine.2014.05.022","volume":"32","author":"N Principi","year":"2014","unstructured":"Principi N, Esposito S. Vaccine use in primary immunodeficiency disorders. Vaccine. 2014;32(30):3725\u201331. https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.022.","journal-title":"Vaccine"},{"issue":"3","key":"749_CR20","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1093\/cid\/cit684","volume":"58","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):e44\u2013100. https:\/\/doi.org\/10.1093\/cid\/cit684.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"749_CR21","first-page":"E115","volume":"57","author":"I Barberis","year":"2016","unstructured":"Barberis I, Myles P, Ault SK, Bragazzi NL, Martini M. History and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccines. J Prev Med Hyg. 2016;57(3):E115\u2013e20.","journal-title":"J Prev Med Hyg"},{"issue":"16","key":"749_CR22","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/S0264-410X(03)00072-0","volume":"21","author":"GA van Essen","year":"2003","unstructured":"van Essen GA, Palache AM, Forleo E, Fedson DS. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine. 2003;21(16):1780\u20135.","journal-title":"Vaccine"},{"key":"749_CR23","unstructured":"Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, Singleton JA. Prevention and control of influenza\u2014recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for disease control and prevention. 2005. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5208a1.htm. Accessed 4 Nov 2013."},{"key":"749_CR24","doi-asserted-by":"publisher","unstructured":"Sperlich JM, Grimbacher B, Workman S, Haque T, Seneviratne SL, Burns SO, et al. Respiratory infections and antibiotic usage in common variable immunodeficiency. J Allergy Clin Immunol Pract. 2017; https:\/\/doi.org\/10.1016\/j.jaip.2017.05.024.","DOI":"10.1016\/j.jaip.2017.05.024"},{"issue":"4","key":"749_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jinf.2016.07.018","volume":"73","author":"E Nanishi","year":"2016","unstructured":"Nanishi E, Hoshina T, Takada H, Ishimura M, Nishio H, Uehara T, et al. A nationwide survey of common viral infections in childhood among patients with primary immunodeficiency diseases. J Inf Secur. 2016;73(4):358\u201368. https:\/\/doi.org\/10.1016\/j.jinf.2016.07.018.","journal-title":"J Inf Secur"},{"issue":"3","key":"749_CR26","first-page":"69","volume":"55","author":"R Gasparini","year":"2014","unstructured":"Gasparini R, Amicizia D, Lai PL, Bragazzi NL, Panatto D. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs. J Prev Med Hyg. 2014;55(3):69\u201385.","journal-title":"J Prev Med Hyg"},{"issue":"4","key":"749_CR27","first-page":"109","volume":"55","author":"R Gasparini","year":"2014","unstructured":"Gasparini R, Amicizia D, Lai PL, Bragazzi NL, Panatto D. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: future compounds against influenza virus. J Prev Med Hyg. 2014;55(4):109\u201329.","journal-title":"J Prev Med Hyg"},{"issue":"12","key":"749_CR28","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1086\/648406","volume":"200","author":"J Beran","year":"2009","unstructured":"Beran J, Vesikari T, Wertzova V, Karvonen A, Honegr K, Lindblad N, et al. Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial. J Infect Dis. 2009;200(12):1861\u20139. https:\/\/doi.org\/10.1086\/648406.","journal-title":"J Infect Dis"},{"key":"749_CR29","doi-asserted-by":"publisher","unstructured":"Demicheli V, Rivetti D, Deeks JJ, Jefferson TO. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2001(4):Cd001269. doi:https:\/\/doi.org\/10.1002\/14651858.cd001269.","DOI":"10.1002\/14651858.cd001269"},{"issue":"2","key":"749_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1586\/14760584.2016.1113878","volume":"15","author":"R Bekkat-Berkani","year":"2016","unstructured":"Bekkat-Berkani R, Ray R, Jain VK, Chandrasekaran V, Innis BL. Evidence update: GlaxoSmithKline\u2019s inactivated quadrivalent influenza vaccines. Expert Rev Vaccines. 2016;15(2):201\u201314. https:\/\/doi.org\/10.1586\/14760584.2016.1113878.","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"749_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<94::AID-JMV15>3.0.CO;2-C","volume":"61","author":"JC de Jong","year":"2000","unstructured":"de Jong JC, Beyer WE, Palache AM, Rimmelzwaan GF, Osterhaus AD. Mismatch between the 1997\/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol. 2000;61(1):94\u20139.","journal-title":"J Med Virol"},{"issue":"15","key":"749_CR32","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1056\/NEJMoa1010331","volume":"365","author":"T Vesikari","year":"2011","unstructured":"Vesikari T, Knuf M, Wutzler P, Karvonen A, Kieninger-Baum D, Schmitt HJ, et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med. 2011;365(15):1406\u201316. https:\/\/doi.org\/10.1056\/NEJMoa1010331.","journal-title":"N Engl J Med"},{"key":"749_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/82_2014_406","volume":"386","author":"G Del Giudice","year":"2015","unstructured":"Del Giudice G, Rappuoli R. Inactivated and adjuvanted influenza vaccines. Curr Top Microbiol Immunol. 2015;386:151\u201380. https:\/\/doi.org\/10.1007\/82_2014_406.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"4","key":"749_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cmi.2017.02.009","volume":"23","author":"R Nachbagauer","year":"2017","unstructured":"Nachbagauer R, Krammer F. Universal influenza virus vaccines and therapeutic antibodies. Clin Microbiol Infect. 2017;23(4):222\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2017.02.009.","journal-title":"Clin Microbiol Infect"},{"key":"749_CR35","doi-asserted-by":"publisher","unstructured":"Singanayagam A, Zambon M, Lalvani A, Barclay W. Urgent challenges in implementing live attenuated influenza vaccine. Lancet Infect Dis. 2017; https:\/\/doi.org\/10.1016\/s1473-3099(17)30360-2.","DOI":"10.1016\/s1473-3099(17)30360-2"},{"key":"749_CR36","doi-asserted-by":"publisher","unstructured":"Nohynek H, Baum U, Syrjanen R, Ikonen N, Sundman J, Jokinen J. Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds\u2014a nationwide cohort study Finland, influenza season 2015\/16. Euro Surveill. 2016;21(38) https:\/\/doi.org\/10.2807\/1560-7917.es.2016.21.38.30346.","DOI":"10.2807\/1560-7917.es.2016.21.38.30346"},{"issue":"1","key":"749_CR37","first-page":"1","volume":"54","author":"A Ceravolo","year":"2013","unstructured":"Ceravolo A, Orsi A, Parodi V, Ansaldi F. Influenza vaccination in HIV-positive subjects: latest evidence and future perspective. J Prev Med Hyg. 2013;54(1):1\u201310.","journal-title":"J Prev Med Hyg"},{"issue":"3","key":"749_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/cid\/civ884","volume":"62","author":"S Garg","year":"2016","unstructured":"Garg S, Thongcharoen P, Praphasiri P, Chitwarakorn A, Sathirapanya P, Fernandez S, et al. Randomized controlled trial to compare immunogenicity of standard-dose intramuscular versus intradermal trivalent inactivated influenza vaccine in HIV-infected men who have sex with men in Bangkok, Thailand. Clin Infect Dis. 2016;62(3):383\u201391. https:\/\/doi.org\/10.1093\/cid\/civ884.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"749_CR39","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3851\/IMP2103","volume":"17","author":"CA Siegrist","year":"2012","unstructured":"Siegrist CA, Ambrosioni J, Bel M, Combescure C, Hadaya K, Martin PY, et al. Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine. Antivir Ther. 2012;17(5):893\u2013903. https:\/\/doi.org\/10.3851\/imp2103.","journal-title":"Antivir Ther"},{"issue":"4","key":"749_CR40","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jaci.2013.11.043","volume":"133","author":"WT Shearer","year":"2014","unstructured":"Shearer WT, Fleisher TA, Buckley RH, Ballas Z, Ballow M, Blaese RM, et al. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol. 2014;133(4):961\u20136. https:\/\/doi.org\/10.1016\/j.jaci.2013.11.043.","journal-title":"J Allergy Clin Immunol"},{"issue":"45","key":"749_CR41","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.1016\/j.vaccine.2016.08.057","volume":"34","author":"E Sparrow","year":"2016","unstructured":"Sparrow E, Friede M, Sheikh M, Torvaldsen S, Newall AT. Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications. Vaccine. 2016;34(45):5442\u20138. https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.057.","journal-title":"Vaccine"},{"issue":"12","key":"749_CR42","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nbt1207-1361","volume":"25","author":"R Rappuoli","year":"2007","unstructured":"Rappuoli R. Bridging the knowledge gaps in vaccine design. Nat Biotechnol. 2007;25(12):1361\u20136. https:\/\/doi.org\/10.1038\/nbt1207-1361.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"749_CR43","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1017\/S0022172400022610","volume":"70","author":"D Hobson","year":"1972","unstructured":"Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg. 1972;70(4):767\u201377.","journal-title":"J Hyg"},{"key":"749_CR44","unstructured":"Committee for Proprietary Medicinical Products CPMP. Note for guidance on harmonisation of requirements for influenza vaccines. European agency for the evaluation of medicinal products (EMEA), London. 1997. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003945.pdf. 2017."},{"issue":"1\u20132","key":"749_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.virusres.2004.02.025","volume":"103","author":"C Hannoun","year":"2004","unstructured":"Hannoun C, Megas F, Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res. 2004;103(1\u20132):133\u20138. https:\/\/doi.org\/10.1016\/j.virusres.2004.02.025.","journal-title":"Virus Res"},{"issue":"12","key":"749_CR46","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","volume":"30","author":"S Black","year":"2011","unstructured":"Black S, Nicolay U, Vesikari T, Knuf M, Del Giudice G, Della Cioppa G, et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J. 2011;30(12):1081\u20135. https:\/\/doi.org\/10.1097\/INF.0b013e3182367662.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"749_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1600-065X.2010.00974.x","volume":"239","author":"PR Dormitzer","year":"2011","unstructured":"Dormitzer PR, Galli G, Castellino F, Golding H, Khurana S, Del Giudice G, et al. Influenza vaccine immunology. Immunol Rev. 2011;239(1):167\u201377. https:\/\/doi.org\/10.1111\/j.1600-065X.2010.00974.x.","journal-title":"Immunol Rev"},{"issue":"3","key":"749_CR48","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.vaccine.2004.07.017","volume":"23","author":"J Puig-Barber\u00e0","year":"2004","unstructured":"Puig-Barber\u00e0 J, Diez-Domingo J, P\u00e9rez Hoyos S, Belenguer Varea A, Gonz\u00e1les VD. Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age. Vaccine. 2004;23(3):283\u20139.","journal-title":"Vaccine"},{"issue":"1","key":"749_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","volume":"59","author":"RJ Cox","year":"2004","unstructured":"Cox RJ, Brokstad KA, Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol. 2004;59(1):1\u201315.","journal-title":"Scand J Immunol"},{"key":"749_CR50","unstructured":"Yewdell JW, Hackett CJ. The influenza viruses. The viruses. Plenum Press New York, USA: Springer US; 1989."},{"issue":"1","key":"749_CR51","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1073\/pnas.0609330104","volume":"104","author":"HH Bui","year":"2007","unstructured":"Bui HH, Peters B, Assarsson E, Mbawuike I, Sette A. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci U S A. 2007;104(1):246\u201351. https:\/\/doi.org\/10.1073\/pnas.0609330104.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"749_CR52","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1128\/JVI.02163-13","volume":"88","author":"KB Westgeest","year":"2014","unstructured":"Westgeest KB, Russell CA, Lin X, Spronken MI, Bestebroer TM, Bahl J, et al. Genomewide analysis of reassortment and evolution of human influenza A(H3N2) viruses circulating between 1968 and 2011. J Virol. 2014;88(5):2844\u201357. https:\/\/doi.org\/10.1128\/jvi.02163-13.","journal-title":"J Virol"},{"issue":"50","key":"749_CR53","doi-asserted-by":"publisher","first-page":"20248","DOI":"10.1073\/pnas.1320524110","volume":"110","author":"NS Heaton","year":"2013","unstructured":"Heaton NS, Sachs D, Chen CJ, Hai R, Palese P. Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins. Proc Natl Acad Sci U S A. 2013;110(50):20248\u201353. https:\/\/doi.org\/10.1073\/pnas.1320524110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"749_CR54","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1093\/molbev\/msr044","volume":"28","author":"S Bhatt","year":"2011","unstructured":"Bhatt S, Holmes EC, Pybus OG. The genomic rate of molecular adaptation of the human influenza A virus. Mol Biol Evol. 2011;28(9):2443\u201351. https:\/\/doi.org\/10.1093\/molbev\/msr044.","journal-title":"Mol Biol Evol"},{"issue":"4","key":"749_CR55","doi-asserted-by":"publisher","first-page":"e93632","DOI":"10.1371\/journal.pone.0093632","volume":"9","author":"EY Klein","year":"2014","unstructured":"Klein EY, Serohijos AW, Choi JM, Shakhnovich EI, Pekosz A. Influenza A H1N1 pandemic strain evolution\u2014divergence and the potential for antigenic drift variants. PLoS One. 2014;9(4):e93632. https:\/\/doi.org\/10.1371\/journal.pone.0093632.","journal-title":"PLoS One"},{"issue":"10","key":"749_CR56","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/nm.3350","volume":"19","author":"S Sridhar","year":"2013","unstructured":"\u2022\u2022 Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W, et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med. 2013;19(10):1305\u201312. https:\/\/doi.org\/10.1038\/nm.3350. Follow up study on 342 healthy adults correlating pre-existing T cells to H1N1 with clinical outcome, demonstrating that CD8 cells specific to conserved viral epitopes correlated with cross-protection against influenza.","journal-title":"Nat Med"},{"issue":"2","key":"749_CR57","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nm.2612","volume":"18","author":"TM Wilkinson","year":"2012","unstructured":"Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med. 2012;18(2):274\u201380. https:\/\/doi.org\/10.1038\/nm.2612.","journal-title":"Nat Med"},{"issue":"10","key":"749_CR58","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.4049\/jimmunol.176.10.6333","volume":"176","author":"JE McElhaney","year":"2006","unstructured":"McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol. 2006;176(10):6333\u20139.","journal-title":"J Immunol"},{"key":"749_CR59","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","volume":"7","author":"TR Mosmann","year":"1989","unstructured":"Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145\u201373. https:\/\/doi.org\/10.1146\/annurev.iy.07.040189.001045.","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"749_CR60","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","volume":"13","author":"PA Darrah","year":"2007","unstructured":"Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med. 2007;13(7):843\u201350. https:\/\/doi.org\/10.1038\/nm1592.","journal-title":"Nat Med"},{"issue":"2","key":"749_CR61","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.4049\/jimmunol.0904209","volume":"185","author":"MG de Goer de Herve","year":"2010","unstructured":"de Goer de Herve MG, Dembele B, Vallee M, Herr F, Cariou A, Taoufik Y. Direct CD4 help provision following interaction of memory CD4 and CD8 T cells with distinct antigen-presenting dendritic cells. J Immunol. 2010;185(2):1028\u201336. https:\/\/doi.org\/10.4049\/jimmunol.0904209.","journal-title":"J Immunol"},{"issue":"10","key":"749_CR62","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.4049\/jimmunol.160.10.5007","volume":"160","author":"HC Su","year":"1998","unstructured":"Su HC, Cousens LP, Fast LD, Slifka MK, Bungiro RD, Ahmed R, et al. CD4+ and CD8+ T cell interactions in IFN-gamma and IL-4 responses to viral infections: requirements for IL-2. J Immunol. 1998;160(10):5007\u201317.","journal-title":"J Immunol"},{"issue":"7","key":"749_CR63","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1128\/CVI.00397-07","volume":"15","author":"BD Forrest","year":"2008","unstructured":"Forrest BD, Pride MW, Dunning AJ, Capeding MR, Chotpitayasunondh T, Tam JS, et al. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin Vaccine Immunol. 2008;15(7):1042\u201353. https:\/\/doi.org\/10.1128\/cvi.00397-07.","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"749_CR64","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.clim.2010.03.430","volume":"136","author":"S van Assen","year":"2010","unstructured":"van Assen S, Holvast A, Telgt DS, Benne CA, de Haan A, Westra J, et al. Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine. Clin Immunol (Orlando, Fla). 2010;136(2):228\u201335. https:\/\/doi.org\/10.1016\/j.clim.2010.03.430.","journal-title":"Clin Immunol (Orlando, Fla)"},{"issue":"21","key":"749_CR65","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.vaccine.2016.03.091","volume":"34","author":"LG Hanitsch","year":"2016","unstructured":"\u2022 Hanitsch LG, Lobel M, Mieves JF, Bauer S, Babel N, Schweiger B, et al. Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency. Vaccine. 2016;34(21):2417\u201323. https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.091. A small study on patients with CVID and other forms of primary antibody deficiency, demonstrating impaired humoral response after influenza vaccination but normal cellular immune response.","journal-title":"Vaccine"},{"issue":"2","key":"749_CR66","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-3083.2011.02561.x","volume":"74","author":"G Pedersen","year":"2011","unstructured":"Pedersen G, Halstensen A, Sjursen H, Naess A, Kristoffersen EK, Cox RJ. Pandemic influenza vaccination elicits influenza-specific CD4+ Th1-cell responses in hypogammaglobulinaemic patients: four case reports. Scand J Immunol. 2011;74(2):210\u20138. https:\/\/doi.org\/10.1111\/j.1365-3083.2011.02561.x.","journal-title":"Scand J Immunol"},{"issue":"2","key":"749_CR67","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.clim.2011.07.004","volume":"141","author":"S van Assen","year":"2011","unstructured":"van Assen S, de Haan A, Holvast A, Horst G, Gorter L, Westra J, et al. Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiency. Clin Immunol (Orlando, Fla). 2011;141(2):161\u20138. https:\/\/doi.org\/10.1016\/j.clim.2011.07.004.","journal-title":"Clin Immunol (Orlando, Fla)"},{"issue":"3","key":"749_CR68","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1182\/blood-2003-04-1203","volume":"103","author":"A Harari","year":"2004","unstructured":"Harari A, Petitpierre S, Vallelian F, Pantaleo G. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood. 2004;103(3):966\u201372. https:\/\/doi.org\/10.1182\/blood-2003-04-1203.","journal-title":"Blood"},{"issue":"1","key":"749_CR69","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/TP.0b013e3181fe1335","volume":"91","author":"K Mueller","year":"2011","unstructured":"Mueller K, Schachtner T, Sattler A, Meier S, Friedrich P, Trydzenskaya H, et al. BK-VP3 as a new target of cellular immunity in BK virus infection. Transplantation. 2011;91(1):100\u20137.","journal-title":"Transplantation"},{"issue":"21","key":"749_CR70","doi-asserted-by":"publisher","first-page":"12071","DOI":"10.1128\/JVI.01261-07","volume":"81","author":"S Kannanganat","year":"2007","unstructured":"Kannanganat S, Kapogiannis BG, Ibegbu C, Chennareddi L, Goepfert P, Robinson HL, et al. Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines. J Virol. 2007;81(21):12071\u20136. https:\/\/doi.org\/10.1128\/jvi.01261-07.","journal-title":"J Virol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-017-0749-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-017-0749-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-017-0749-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:10:44Z","timestamp":1744175444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-017-0749-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,5]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1007\/s11882-017-0749-3","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,5]]},"assertion":[{"value":"5 October 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"78"}}